Angeline Elisabeth Styve Einarsen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Placebo Controlled

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)
Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)
Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)
Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)
Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)
Lise Christine Gaudernack, Angeline Elisabeth Styve Einarsen, Ingvil Krarup Sørbye, Mirjam Lukasse, Nina Gunnes, Trond Melbye Michelsen
The effect of intravenous hyoscine butylbromide on slow progress in labor (BUSCLAB): A double-blind randomized placebo-controlled trial. PLoS medicine 21 (3) (2024)